News

Lux Biosciences, a biotechnology company, has reported positive results from an international Phase III program in uveitis, the Luminate trials, which demonstrated the ability of LX211 to significantly

Novartis has reported that Glivec has received approval from the European Commission to become the first and only treatment available in Europe to reduce the risk of recurrence

SuperGen, a US-based pharmaceutical company, has reported that Phase Ib data for MP-470, its multi-targeted, tyrosine kinase inhibitor and RAD51 suppressor, demonstrated an overall clinical benefit rate of

Sequella, a clinical stage biopharmaceutical company, has started its Phase Ib trial for SQ109 with the dosing of the first cohort of volunteers. The Phase Ib study will

System C Healthcare, a provider of IT products and services to the healthcare sector, has acquired the Bluestar UK Group, a developer of healthcare IT solutions, for a

Gene Network Sciences, a biotechnology company, has received a US patent that covers the company’s core model learning and simulation platform, REFS. Gene Network Sciences (GNS) has deployed

Evoke Pharma, a specialty pharmaceutical company, has initiated a Phase IIb clinical trial to evaluate EVK-001 for the treatment of adults with symptoms of diabetic gastroparesis. The metoclopramide

Clarient, a provider of anatomic pathology and molecular testing services, has launched a new breast cancer test that helps physicians identify the probability of a patient’s cancer recurring

According to Sanofi Pasteur, this new facility, located in Swiftwater, Pennsylvania, will incorporate the latest technology in egg-based vaccine production as part of the company’s commitment to produce